Published in Blood Weekly, May 1st, 2003
The researchers used 12B1 tumor cells to generate CRCL fractions, which were then used to incubate carrier DCs. 12B1 is an "aggressive bcr-abl positive murine leukemia,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.